Thalassemia Minor and Major: Current Management.
Choudhry VP.
Indian J Pediatr. 2017 Aug;84(8):607-611. doi: 10.1007/s12098-017-2325-1. Epub 2017 Apr 24.
Cardiovascular magnetic resonance in beta-thalassemia major: beyond T2.
Meloni A, Saba L, Cademartiri F, Positano V, Pistoia L, Cau R.
Radiol Med. 2024 Dec;129(12):1812-1822. doi: 10.1007/s11547-024-01916-6. Epub 2024 Nov 7.
Changing patterns in the epidemiology of beta-thalassemia.
Kattamis A, Forni GL, Aydinok Y, Viprakasit V.
Eur J Haematol. 2020 Dec;105(6):692-703. doi: 10.1111/ejh.13512. Epub 2020 Sep 21.
Retinal abnormalities in beta-thalassemia major.
Bhoiwala DL, Dunaief JL.
Surv Ophthalmol. 2016 Jan-Feb;61(1):33-50. doi: 10.1016/j.survophthal.2015.08.005. Epub 2015 Aug 29.
Speckle tracking echocardiography and beta-thalassemia major. A systematic review.
Patsourakos D, Aggeli C, Dimitroglou Y, Delicou S, Xydaki K, Koukos M, Tsartsalis D, Gialeli F, Gatzoulis KA, Tousoulis D, Tsioufis K.
Ann Hematol. 2024 Sep;103(9):3335-3356. doi: 10.1007/s00277-023-05380-6. Epub 2023 Aug 1.
Thalassemia major 1995: older patients, new therapies.
Rund D, Rachmilewitz E.
Blood Rev. 1995 Mar;9(1):25-32. doi: 10.1016/0268-960x(95)90037-3.
Major Thalassemia, Screening or Treatment: An Economic Evaluation Study in Iran.
Esmaeilzadeh F, Ahmadi B, Vahedi S, Barzegari S, Rajabi A.
Int J Health Policy Manag. 2022 Jul 1;11(7):1112-1119. doi: 10.34172/ijhpm.2021.04. Epub 2021 Feb 3.
Can silymarin ameliorate beta-thalassemia major-induced osteopenia/osteoporosis?
Darvishi-Khezri H.
J Complement Integr Med. 2021 May 26;19(2):471-472. doi: 10.1515/jcim-2020-0111. eCollection 2022 Jun 1.
Allogeneic stem cell transplantation for thalassemia major.
Angelucci E, Baronciani D.
Haematologica. 2008 Dec;93(12):1780-4. doi: 10.3324/haematol.2008.001909.
[Psychosocial and academic consequences of beta-thalassemia major in Tunisia].
Barouni M, Aroua S, Mellouli F, Bejaoui M, Abbes S.
Soins Pediatr Pueric. 2019 May-Jun;40(308):38-42. doi: 10.1016/j.spp.2019.03.008.
